CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy

被引：1
|
作者：
Wilton-Clark, Harry [1 ]
Yokota, Toshifumi [1 ]
机构：
[1] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada
来源：
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT | 2023年 / 30卷
关键词：
D O I：
10.1016/j.omtm.2023.08.013
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：500 / 501
页数：2
相关论文
共 50 条
  • [1] Exon skipping in Duchenne muscular dystrophy
    Wilton, Steve
    NEUROMUSCULAR DISORDERS, 2008, 18 (05) : 431 - 432
  • [2] Exon skipping: a first in class strategy for Duchenne muscular dystrophy
    Niks, Erik H.
    Aartsma-Rus, Annemieke
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (02) : 225 - 236
  • [3] Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy
    Aartsma-Rus, Annemieke
    Heemskerk, Hans
    de Winter, Christa
    van Putten, Maaike
    Janson, Anneke
    Verschuuren, Jan
    den Dunnen, Johan
    van Deutekom, Judith
    van Ommen, Gert-Jan
    HUMAN GENE THERAPY, 2009, 20 (06) : 660 - 661
  • [4] Production of Duchenne muscular dystrophy cellular model using CRISPR-Cas9 exon deletion strategy
    Alizadeh, Farzaneh
    Abraghan, Yousef Jafari
    Farrokhi, Shima
    Yousefi, Yasamin
    Mirahmadi, Yeganeh
    Eslahi, Atieh
    Mojarrad, Majid
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, 479 (05) : 1027 - 1040
  • [5] A novel human muscle cell model of Duchenne muscular dystrophy created by CRISPR/Cas9 and evaluation of antisense-mediated exon skipping
    Shimo, Takenori
    Hosoki, Kana
    Nakatsuji, Yusuke
    Yokota, Toshifumi
    Obika, Satoshi
    JOURNAL OF HUMAN GENETICS, 2018, 63 (03) : 365 - 375
  • [6] A novel human muscle cell model of Duchenne muscular dystrophy created by CRISPR/Cas9 and evaluation of antisense-mediated exon skipping
    Takenori Shimo
    Kana Hosoki
    Yusuke Nakatsuji
    Toshifumi Yokota
    Satoshi Obika
    Journal of Human Genetics, 2018, 63 : 365 - 375
  • [7] Gene modification strategies using AO-mediated exon skipping and CRISPR/Cas9 as potential therapies for Duchenne muscular dystrophy patients
    Solberg, Marthe Helene
    Shariatzadeh, Maryam
    Wilson, Samantha L.
    Engineering Biology, 2020, 4 (03) : 37 - 42
  • [8] Exon-Skipping in Duchenne Muscular Dystrophy
    Takeda, Shin ichi
    Clemens, Paula R.
    Hoffman, Eric P.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 : S343 - S358
  • [9] Exon skipping therapy for Duchenne muscular dystrophy
    Kole, Ryszard
    Krieg, Arthur M.
    ADVANCED DRUG DELIVERY REVIEWS, 2015, 87 : 104 - 107
  • [10] The Future of Exon Skipping for Duchenne Muscular Dystrophy
    Aartsma-Rus, Annemieke
    HUMAN GENE THERAPY, 2023, 34 (9-10) : 372 - 378
12345